Clovis slumps after FDA asks for more data on lung cancer drug

Nov 16 (Reuters) - Clovis Oncology Inc said the U.S. Food and Drug Administration asked for additional clinical data on the effectiveness of its experimental lung cancer drug, rociletinib, which...